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1726-4Imaging evaluation of osteoporotic vertebral fractureAs the world's population ages, the incidence of osteopo-
rosis defined by decreased bone mass and alteration of
microarchitecture has inevitably increased. This results in
osteoporosis-associated fracture and leads to debilitating
health outcomes and a considerable economic burden on the
health care system.1,2 In this issue of the Journal of the Chi-
nese Medical Association, Lin and colleagues have contributed
an interesting article entitled Determination of the painful
level in osteoporotic vertebral fractures: retrospective com-
parison between plain film, bone scan, and magnetic reso-
nance imaging.3 The authors studied 52 patients with
osteoporotic vertebral fracture (OVF) treated by vertebroplasty
in a single institute in Northern Taiwan and found that the pain
level of single-level compression vertebral fracture could be
identified accurately by either plain film or bone scan; how-
ever, the pain level of multiple-level compression vertebral
fractures should necessitate the use of magnetic resonance
imaging (MRI) to provide an improved and more sensitive
diagnosis to localize multiple sites of vertebral fractures.3 In
addition, when a vacuum cleft sign appeared on plain film in
patients with supposed vertebral fractures, two other diag-
nostic tools, bone scan and MRI, both showed positive find-
ings.3 Although we applaud the successful publication of this
article, there are several controversial issues that require fur-
ther discussion.
First, what is the aim of this study? In our understanding,
the authors would like to localize the fracture sites of the
osteoporotic vertebral bones more precisely by comparing the
detection accuracy of three commonly used tools: plain film,
bone scan, and MRI. However, it is unknown why the authors
compared pain score (visual analog scale) of these 52 patients
with OVF treated by vertebroplasty, preoperatively and post-
operatively. As would be expected, patients after treatment had
a significant decline of pain score from 7.6 to 2.8. However,
this reduced pain score might in fact represent the benefits or
effectiveness of the use of vertebroplasty in the management
of patients with OVF. However, this was not a main outcome
of the study and, furthermore, was not a conclusion presented
by the authors. A recent meta-analysis from Tian et al4 showed
that patients with OVF treated by vertebroplasty had statisti-
cally significant improvements in pain relief compared with
the traditional treatment. Additionally, there was the similar
incidence of adjacent vertebral fracture between those patientsx.doi.org/10.1016/j.jcma.2015.04.009
901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Asstreated by vertebroplasty and traditional treatment.4 Therefore,
it would be our suggestion that the method for Dr. Lin's3 study
in this issue should more productively focus on the cost-
effectiveness or convenience of these different diagnostic
tools.
Second, it remains unknown as to why the authors said that
it is difficult to determine the actual painful vertebral level in
the evaluation of OVF, especially when there are simultaneous
acute and chronic fractures. Has there been an alteration in the
treatment of vertebroplasty for acute or chronic OVF? The
authors failed to study or discuss this. Son et al5 found that
early vertebroplasty might achieve a better immediate surgical
result with improved cost-effectiveness, suggesting that
accurate localization of new onset of OVF could be of con-
siderable importance. Since the authors commented that MRI
was further needed in cases involving multiple OVF, did the
authors mean that the use of MRI could clearly distinguish the
new and old OVF in these patients? By contrast, Tan et al6 in
their prospective study showed that vertebroplasty was effec-
tive in patients with chronic painful OVF and pain relief after
vertebroplasty was immediate. This might suggest that dif-
ferential diagnosis between acute and chronic OVF might not
have any influence on the therapeutic effects of vertebroplasty.
Third, it is still undetermined as to whether all fracture sites
of vertebral bodies of patients with multiple OVF could be
simultaneously corrected by vertebroplasty. It is also uncertain
whether patients with multiple OVF would benefit by cor-
rection of all fracture sites by vertebroplasty at once. Saracen
and Kotwica7 found that vertebroplasty significantly dimin-
ished the level of pain in 90% of patients with multiple OVF
and suggested that this procedure should be seriously con-
sidered as an efficacious choice of treatment.
Finally, vertebroplasty is a minimally invasive procedure
intended to relieve pain and reduce disability in people with
OVF; however, the potential complications and cost-
effectiveness of the procedure should always be kept in
mind. In addition, double-blinded trials associated with ver-
tebroplasty were shown to have no more benefit than local
anaesthesia.8 Therefore, the use of multimodality assessment
to provide scientific evidence in vertebroplasty selection and
planning is encouraged for all patients, to help obtain cost-
effective and accurate results and further reduce the risk of
mortality.ociation. All rights reserved.
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